282 related articles for article (PubMed ID: 25407863)
21. Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer.
Dess RT; Sun Y; Jackson WC; Jairath NK; Kishan AU; Wallington DG; Mahal BA; Stish BJ; Zumsteg ZS; Den RB; Hall WA; Gharzai LA; Jaworski EM; Reichert ZR; Morgan TM; Mehra R; Schaeffer EM; Sartor O; Nguyen PL; Lee WR; Rosenthal SA; Michalski JM; Schipper MJ; Dignam JJ; Pisansky TM; Zietman AL; Sandler HM; Efstathiou JA; Feng FY; Shipley WU; Spratt DE
JAMA Oncol; 2020 May; 6(5):735-743. PubMed ID: 32215583
[TBL] [Abstract][Full Text] [Related]
22. Utilization of Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy.
Hawken SR; Spratt DE; Qi J; Linsell SM; Cher ML; Ghani KR; Miller DC; Montie JE; Morgan TM;
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1030-1034. PubMed ID: 30682490
[TBL] [Abstract][Full Text] [Related]
23. Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure.
Jackson WC; Suresh K; Tumati V; Dess RT; Soni PD; Zhao SG; Zumsteg ZS; Hannan R; Hollenbeck BK; George A; Kaffenberger SD; Salami SS; Hearn JWD; Morgan TM; Mehra R; Schipper M; Feng FY; Desai NB; Spratt DE
Eur Urol Oncol; 2018 Sep; 1(4):276-282. PubMed ID: 31100248
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy after radical prostatectomy for prostate cancer: clinical outcomes and factors influencing biochemical recurrence.
Fukuda I; Aoki M; Kimura T; Ikeda K
Ir J Med Sci; 2023 Dec; 192(6):2663-2671. PubMed ID: 37097540
[TBL] [Abstract][Full Text] [Related]
25. The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy.
Ishikawa H; Higuchi K; Kaminuma T; Takezawa Y; Saito Y; Etsunaga T; Maruo K; Kawamura H; Kubo N; Nakano T; Kobayashi M
J Radiat Res; 2020 Nov; 61(6):908-919. PubMed ID: 32888035
[TBL] [Abstract][Full Text] [Related]
26. Prostate-specific antigen after salvage radiotherapy for postprostatectomy biochemical recurrence predicts long-term outcome including overall survival.
Bartkowiak D; Thamm R; Bottke D; Siegmann A; Böhmer D; Budach V; Wiegel T
Acta Oncol; 2018 Mar; 57(3):362-367. PubMed ID: 28816074
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy.
Oehus AK; Kroeze SGC; Schmidt-Hegemann NS; Vogel MME; Kirste S; Becker J; Burger IA; Derlin T; Bartenstein P; Eiber M; Mix M; la Fougère C; Belka C; Combs SE; Grosu AL; Müller AC; Guckenberger M; Christiansen H; Henkenberens C
BMC Cancer; 2020 Apr; 20(1):362. PubMed ID: 32349700
[TBL] [Abstract][Full Text] [Related]
28. Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.
Ying J; Wang CJ; Yan J; Liauw SL; Straka C; Pistenmaa D; Xie XJ; Lotan Y; Roehrborn C; Kim DN
Am J Clin Oncol; 2017 Dec; 40(6):612-620. PubMed ID: 26165416
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.
Taylor N; Kelly JF; Kuban DA; Babaian RJ; Pisters LL; Pollack A
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):755-63. PubMed ID: 12788182
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy.
Tilki D; Preisser F; Tennstedt P; Tober P; Mandel P; Schlomm T; Steuber T; Huland H; Schwarz R; Petersen C; Graefen M; Ahyai S
BJU Int; 2017 May; 119(5):717-723. PubMed ID: 27743493
[TBL] [Abstract][Full Text] [Related]
31. Salvage radiotherapy in patients with prostate cancer and biochemical relapse after radical prostatectomy : Long-term follow-up of a single-center survey.
Lohm G; Lütcke J; Jamil B; Höcht S; Neumann K; Hinkelbein W; Wiegel T; Bottke D
Strahlenther Onkol; 2014 Aug; 190(8):727-31. PubMed ID: 24577132
[TBL] [Abstract][Full Text] [Related]
32. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer.
Kishan AU; Tendulkar RD; Tran PT; Parker CC; Nguyen PL; Stephenson AJ; Carrie C
Eur Urol Oncol; 2018 May; 1(1):3-18. PubMed ID: 31100226
[TBL] [Abstract][Full Text] [Related]
33. Ten-Year Outcomes of Moderately Hypofractionated Salvage Postprostatectomy Radiation Therapy and External Validation of a Contemporary Multivariable Nomogram for Biochemical Failure.
Chin S; Fatimilehin A; Walshaw R; Argarwal A; Mistry H; Elliott T; Logue J; Wylie J; Choudhury A
Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):288-296. PubMed ID: 31987961
[TBL] [Abstract][Full Text] [Related]
34. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
Stephenson AJ; Scardino PT; Kattan MW; Pisansky TM; Slawin KM; Klein EA; Anscher MS; Michalski JM; Sandler HM; Lin DW; Forman JD; Zelefsky MJ; Kestin LL; Roehrborn CG; Catton CN; DeWeese TL; Liauw SL; Valicenti RK; Kuban DA; Pollack A
J Clin Oncol; 2007 May; 25(15):2035-41. PubMed ID: 17513807
[TBL] [Abstract][Full Text] [Related]
35. The PSA-response to salvage radiotherapy after radical prostatectomy correlates with freedom from progression and overall survival.
Bartkowiak D; Bottke D; Thamm R; Siegmann A; Hinkelbein W; Wiegel T
Radiother Oncol; 2016 Jan; 118(1):131-5. PubMed ID: 26653358
[TBL] [Abstract][Full Text] [Related]
36. Salvage radiation therapy for prostate cancer patients after prostatectomy.
Mima T; Ohori M; Hirasawa Y; Mikami R; Arai A; Hashimoto T; Satake N; Gondo T; Nakagami Y; Namiki K; Tokuuye K; Ohno Y
Jpn J Clin Oncol; 2019 Mar; 49(3):281-286. PubMed ID: 30608594
[TBL] [Abstract][Full Text] [Related]
37. Survival analysis of patients with prostate cancer and unfavorable risk factors treated with radical prostatectomy and salvage radiotherapy after biochemical recurrence and persistence.
Barbas Bernardos G; Herranz Amo F; González San Segundo C; Caño Velasco J; Subirá Ríos D; Moralejo Gárate M; Mayor de Castro J; Aragón Chamizo J; Hernández Fernández C
Actas Urol Esp (Engl Ed); 2020 Dec; 44(10):701-707. PubMed ID: 32595092
[TBL] [Abstract][Full Text] [Related]
38. Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debate.
Budäus L; Schiffmann J; Graefen M; Huland H; Tennstedt P; Siegmann A; Böhmer D; Budach V; Bartkowiak D; Wiegel T
Strahlenther Onkol; 2017 Sep; 193(9):692-699. PubMed ID: 28470414
[TBL] [Abstract][Full Text] [Related]
39. More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional Analysis.
Fossati N; Parker WP; Karnes RJ; Colicchia M; Bossi A; Seisen T; Di Muzio N; Cozzarini C; Noris Chiorda B; Fiorino C; Gandaglia G; Bartkowiak D; Wiegel T; Shariat S; Goldner G; Battaglia A; Joniau S; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A; Boorjian SA
Eur Urol; 2018 Aug; 74(2):134-137. PubMed ID: 29544737
[TBL] [Abstract][Full Text] [Related]
40. Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.
Ghadjar P; Aebersold DM; Albrecht C; Böhmer D; Flentje M; Ganswindt U; Höcht S; Hölscher T; Sedlmayer F; Wenz F; Zips D; Wiegel T;
Strahlenther Onkol; 2018 Jul; 194(7):619-626. PubMed ID: 29383406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]